目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Distribution channel
Market segments
Comparison by Distribution channel
Offline - Market size and forecast 2020-2025
Online - Market size and forecast 2020-2025
Market opportunity by Distribution channel

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
AbbVie Inc.
Amgen Inc.
AstraZeneca Plc
Bayer AG
GlaxoSmithKline Plc
Merck KGaA
Mylan NV
Novartis AG
Novo Nordisk AS
Pfizer Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Distribution channel - Market share 2020-2025 (%)
22: Comparison by Distribution channel
23: Offline - Market size and forecast 2020-2025 ($ million)
24: Offline - Year-over-year growth 2020-2025 (%)
25: Online - Market size and forecast 2020-2025 ($ million)
26: Online - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Distribution channel
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: AbbVie Inc. - Overview
48: AbbVie Inc. - Product and service
49: AbbVie Inc. - Key offerings
50: AbbVie Inc. - Key customers
51: AbbVie Inc. - Segment focus
52: Amgen Inc. - Overview
53: Amgen Inc. - Business segments
54: Amgen Inc. - Key offerings
55: Amgen Inc. - Key customers
56: Amgen Inc. - Segment focus
57: AstraZeneca Plc - Overview
58: AstraZeneca Plc - Product and service
59: AstraZeneca Plc - Key offerings
60: AstraZeneca Plc - Key customers
61: AstraZeneca Plc - Segment focus
62: Bayer AG - Overview
63: Bayer AG - Business segments
64: Bayer AG - Key offerings
65: Bayer AG - Key customers
66: Bayer AG - Segment focus
67: GlaxoSmithKline Plc - Overview
68: GlaxoSmithKline Plc - Business segments
69: GlaxoSmithKline Plc - Key offerings
70: GlaxoSmithKline Plc - Key customers
71: GlaxoSmithKline Plc - Segment focus
72: Merck KGaA - Overview
73: Merck KGaA - Business segments
74: Merck KGaA - Key offerings
75: Merck KGaA - Key customers
76: Merck KGaA - Segment focus
77: Mylan NV - Overview
78: Mylan NV - Business segments
79: Mylan NV - Key offerings
80: Mylan NV - Key customers
81: Mylan NV - Segment focus
82: Novartis AG - Overview
83: Novartis AG - Business segments
84: Novartis AG - Key offerings
85: Novartis AG - Key customers
86: Novartis AG - Segment focus
87: Novo Nordisk AS - Overview
88: Novo Nordisk AS - Business segments
89: Novo Nordisk AS - Key offerings
90: Novo Nordisk AS - Key customers
91: Novo Nordisk AS - Segment focus
92: Pfizer Inc. - Overview
93: Pfizer Inc. - Business segments
94: Pfizer Inc. - Key offerings
95: Pfizer Inc. - Key customers
96: Pfizer Inc. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations